Biweekly irinotecan (CPT-11) or tomudex (TOM) followed by levo-leucovorin (LLV)-modulated 5FU i.v. bolus in advanced colorectal carcinoma (ACC). A Southern Italy Cooperative Group (SICOG) randomised study.
ANNALS OF ONCOLOGY（2000）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined